Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts. Export articles to Mendeley Get article recommendations from ACS based on references in your ...

Promising Mucopolysaccharidosis Type I Pipeline Therapies such as Laronidase, Antihistamine, Antipyretic, JR-171, AGT-181, ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

However, although the level of investment in pharmaceutical research and development (R&D) has increased dramatically during this period — to US$50 billion per year at present 1 — the number ...

Japan Year Ended March 31 GROUP 2025 2024 Revenue Y33.07 bln Y42.87 bln Operating Profit (Y6.65 bln) Y7.53 bln Pretax Profit (Y7.48 bln) Y7.26 bln Net Profit (Y4.76 bln) Y5.51 bln Per share Earnings ...

WEST CONSHOHOCKEN – Medicus Pharma Ltd. has agreed to acquire Antev Ltd., a British late clinical-stage drug development company. The two companies recently entered into a binding letter of ...

Combined, Johnson & Johnson, Roche and Regeneron Pharmaceuticals have committed to more than $100B in planned investments. Drugmakers’ business models may also have to change, with companies ...

US$0.30 loss per share (improved from US$0.54 loss in 1Q 2024). We've discovered 1 warning sign about Mirum Pharmaceuticals. View them for free. Revenue exceeded analyst estimates by 13%.

In this article, we are going to take a look at where Terns Pharmaceuticals, Inc. (NASDAQ:TERN) stands against other low risk high reward stocks set to triple by 2030. The market is getting tough ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR") announced today that it will present updated preclinical data from its proprietary J-Brain Cargo®-applied adeno-associated virus (AAV) vector gene ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) announced today that it will present updated preclinical data from its proprietary J-Brain Cargo®-applied adeno-associated virus (AAV ...

In March, MIRA Pharmaceuticals signed a binding letter of intent (LOI) to acquire SKNY Pharmaceuticals. Under the terms, MIRA will acquire SKNY through a stock exchange, whereby SKNY ...